Halozyme Therap Drug Patent Portfolio
Halozyme Therap owns 1 orange book drug protected by 1 US patent Given below is the list of Halozyme Therap's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7767429 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof | 23 Sep, 2027 | Active |
Latest Legal Activities on Halozyme Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Halozyme Therap.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 12th Year, Large Entity | 01 Dec, 2021 | US7767429 (Litigated) |
Payment of Maintenance Fee, 8th Year, Large Entity | 08 Jan, 2018 | US7767429 (Litigated) |
Change in Power of Attorney (May Include Associate POA)
Critical
| 04 Apr, 2011 | US7767429 (Litigated) |
Correspondence Address Change
Critical
| 30 Mar, 2011 | US7767429 (Litigated) |
Sequence Moved to Public Database | 09 Aug, 2010 | US7767429 (Litigated) |
Recordation of Patent Grant Mailed
Critical
| 03 Aug, 2010 | US7767429 (Litigated) |
Patent Issue Date Used in PTA Calculation
Critical
| 03 Aug, 2010 | US7767429 (Litigated) |
Issue Notification Mailed
Critical
| 14 Jul, 2010 | US7767429 (Litigated) |
Printer Rush- No mailing | 25 Jun, 2010 | US7767429 (Litigated) |
Pubs Case Remand to TC
Critical
| 22 Jun, 2010 | US7767429 (Litigated) |
Dispatch to FDC | 07 Jun, 2010 | US7767429 (Litigated) |
Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 01 Jun, 2010 | US7767429 (Litigated) |
Record a Petition Decision of Granted for Patent Term Adjustment after Allowance | 01 Jun, 2010 | US7767429 (Litigated) |
Adjustment of PTA Calculation by PTO | 31 May, 2010 | US7767429 (Litigated) |
Mail Response to 312 Amendment (PTO-271)
Critical
| 11 Mar, 2010 | US7767429 (Litigated) |
Halozyme Therap's Family Patents
Halozyme Therap Drug List
Given below is the complete list of Halozyme Therap's drugs and the patents protecting them.
1. Hylenex Recombinant
Hylenex Recombinant is protected by 1 patent, which is still active. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US7767429 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
23 Sep, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hylenex Recombinant's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List